Wendy B. Young - Mar 12, 2025 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role: Director
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol: RAPP
Transactions as of: Mar 12, 2025
Transactions value $: $61,250
Form type: 4
Date filed: 3/13/2025, 05:00 PM
Previous filing: Nov 7, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RAPP	Common Stock	Purchase	$61.2K	+6K		$10.21	6K	Mar 12, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.20 to $10.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.20 to $10.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.